Ann: Appendix 4E & Annual Report to shareholders, page-23

4$,

they work hard behind the curtains, be assured. LC is accelerating where possible but things take time. Compared to other drug developments IMU is a Ferrari which never had to come in for an additional pit stop as the crew is preparing every step 100%. No trial news here is good news as the patients are alive. That's what the drug companies are looking for, a drug that extends life expectancy. IMU wants on top of that a cure which seems to become more than just likely. But it all takes time and as always the sp drifts down when there is no update. So, can't wait? Sell. But there can always be THE anns the next day. And for the upcoming trials they are already enrolling / waiting for the green light to enroll.

IMO, all is good.

GLTA